Generic Sweden AB AI Stock Analysis
Want to see SE:GENI full AI Analyst Report?
Generic Sweden AB (GENI) AI Stock Analysis
Generic Sweden AB
(Nasdaq OMX AB:GENI)
The company's pristine, debt-free balance sheet and exceptional cash flow generation are the most significant strengths, providing a solid foundation. This is complemented by an attractive shareholder yield and reasonable valuation. The main risk weighing on the score is the sharp deceleration in revenue growth, which is also reflected in the stock's position below its 200-day moving average, signaling caution on the long-term trend.
Generic Sweden AB (GENI) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 436.98M
- Dividend Yield
- 4.92%
- Average Volume (3M)
- 24.86K
- Price to Earnings (P/E)
- 13.6
- Beta (1Y)
- 0.45
- Revenue Growth
- 6.03%
- EPS Growth
- -0.15%
- Country
- Sweden
- Employees
- 21
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Application
Generic Sweden AB Business Overview & Revenue Model
Company Description
Operating as a technology firm, Generic Sweden AB delivers messaging functionalities compatible with any application. The company additionally furnishes a comprehensive platform dedicated to digital communication services. Established in 1993, its co...
Generic Sweden AB Financial Statement Overview
Summary
Generic Sweden exhibits strong financial health with high profitability, a debt-free balance sheet, and excellent free cash flow conversion above 93%. The primary concern is a sharp deceleration in revenue growth to 2.3% TTM, which tempers an otherwise stellar performance.
Income Statement
78PositiveBalance Sheet
85Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 192.18M | 183.71M | 176.45M | 142.59M | 127.73M | 114.23M |
| Gross Profit | 49.36M | 38.81M | 44.72M | 38.27M | 35.54M | 31.93M |
| EBITDA | 40.19M | 39.58M | 35.52M | 30.16M | 26.88M | 24.25M |
| Net Income | 31.79M | 31.04M | 27.25M | 23.31M | 20.45M | 18.13M |
Balance Sheet | ||||||
| Total Assets | 97.14M | 105.14M | 88.97M | 77.42M | 68.04M | 59.42M |
| Cash, Cash Equivalents and Short-Term Investments | 45.78M | 58.24M | 40.62M | 37.20M | 32.60M | 31.07M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 36.39M | 38.55M | 33.75M | 31.01M | 29.57M | 29.11M |
| Stockholders Equity | 60.74M | 66.59M | 55.22M | 46.41M | 38.47M | 30.31M |
Cash Flow | ||||||
| Free Cash Flow | 31.12M | 38.98M | 21.85M | 19.97M | 13.82M | 18.44M |
| Operating Cash Flow | 32.79M | 39.73M | 24.06M | 21.84M | 16.85M | 19.89M |
| Investing Cash Flow | 12.33M | -2.44M | 9.79M | -13.87M | -3.03M | -1.45M |
| Financing Cash Flow | -21.51M | -19.67M | -18.44M | -15.37M | -12.29M | -9.83M |
Generic Sweden AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:GENI, the sentiment is Negative. The current price of 35.40 is below the 20-day moving average (MA) of 37.30, below the 50-day MA of 38.21, and below the 200-day MA of 37.76, indicating a bearish trend. The MACD of -0.50 indicates Positive momentum. The RSI at 35.12 is Neutral, neither overbought nor oversold. The STOCH value of 2.55 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:GENI.
Generic Sweden AB Peers Comparison
Overall Rating
SE:LIME79Outperform
SE:UPSALE78Outperform
SE:GENI77Outperform
SE:ONEF60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | SEK 3.43B | 27.90 | 32.20% | 1.75% | 8.57% | 17.98% | |
| 78Outperform | SEK 431.06M | 15.80 | ― | 8.49% | 11.34% | 40.60% | |
| 77Outperform | SEK 436.98M | 13.62 | ― | 4.92% | 6.03% | -0.15% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 60Neutral | SEK 497.31M | -53.18 | ― | ― | 20.62% | 85.64% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:GENI | Generic Sweden AB | 35.40 | -7.74 | -17.95% | |
| SE:DONE | 24Sevenoffice Scandinavia Ab | 5.48 | -0.20 | -3.52% | |
| SE:LIME | Lime Technologies AB | 252.50 | -58.23 | -18.74% | |
| SE:UPSALE | Upsales Technology AB | 24.90 | -5.25 | -17.42% | |
| SE:ONEF | Oneflow AB | 17.10 | -8.90 | -34.23% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 21, 2026
